Laboratory News and Research

RSS

Study: Warburg effect promotes rapid cell proliferation and tumor growth

A team of scientists led by Professor Adrian Krainer, Ph.D., of Cold Spring Harbor Laboratory has discovered molecular factors in cancer cells that boost the production of an enzyme that helps alter the cells' glucose metabolism. The altered metabolic state, called the Warburg effect, promotes extremely rapid cell proliferation and tumor growth. Adrian Krainer, Ph.D.

23 Jan 2010

USPTO issues new patent for Advaxis' intellectual property portfolio

The U.S. Patent and Trademark Office (USPTO) issued today patent 7,635,479, "Compositions and Methods for Enhancing the Immunogenicity of Antigens,” by Dr. Yvonne Paterson, et al, which is assigned to the Trustees of the University of Pennsylvania and licensed to Advaxis, Incorporated (OTCBB: ADXS).

22 Jan 2010

Findings offer potential significance to the recovery of walking after spinal cord injury

Researchers at the medical university Karolinska Institutet have created a genetically modified mouse in which certain neurons can be activated by blue light. Shining blue light on brainstems or spinal cords isolated from these mice produces walking-like motor activity. The findings, which are published in the scientific journal Nature Neuroscience, are of potential significance to the recovery of walking after spinal cord injury.

22 Jan 2010

Simple, five minute saliva test to determine baby's risk for more than 100 life-threatening genetic diseases

Genetic diseases like those seen in the new Harrison Ford movie "Extraordinary Measures" can now be prevented with a simple saliva test which is free with insurance for more than 100 million Americans.

22 Jan 2010

Rise in US springtime ozone levels could impact compliance with Clean Air Act standards

Springtime ozone levels above western North America are rising primarily due to air flowing eastward from the Pacific Ocean, a trend that is largest when the air originates in Asia. These increases in ozone could make it more difficult for the United States to meet Clean Air Act standards for ozone pollution at ground level, according to a new international study.

22 Jan 2010

New study concerning the severity of H1N1 influenza published in CMAJ

A new study published in CMAJ (Canadian Medical Association Journal) http://www.cmaj.ca/cgi/doi/10.1503/cmaj.091884 concerning the severity of H1N1 influenza has found that admissions to an intensive care unit (ICU) were associated with a longer interval between symptom onset and treatment with antivirals and with presence of an underlying medical condition.

22 Jan 2010

Ordinary face masks and hand hygiene can reduce transmission of influenza-like illness

Ordinary face masks and hand hygiene can effectively reduce the transmission of influenza-like illness during flu season. The finding comes from a new study, now available online (http://www.journals.uchicago.edu/doi/abs/10.1086/650396), published in the Feb. 15 issue of the Journal of Infectious Diseases.

22 Jan 2010

CPRIT awards the first $61M in grants for cancer research

The Cancer Prevention and Research Institute of Texas (CPRIT) awarded on January 20th the first $61 million in grants for cancer research projects at academic institutions and private companies throughout Texas. These are the inaugural grants of the $3 billion to be invested in cancer research in Texas over the next ten years.

21 Jan 2010

Exalenz Bioscience finalizes production of its BreathID System for detecting H. pylori bacteria

Exalenz Bioscience has finalized production of the BreathID® and is preparing to ship the first devices and kits that are used in the detection of Helicobacter pylori bacteria. Additionally, in preparation for its American launch, the company is in the process of establishing national distribution channels. The company has recently announced the appointment of Mr. Dennis Boyle as Vice-President and National Manager in the USA. In his previous position, Mr. Boyle was director of sales and marketing to medical laboratories for Siemens USA.

21 Jan 2010

Phoenix Controls announces the introduction of APM2

Phoenix Controls, a Honeywell International business, today announced the introduction of the Advanced Pressure Monitor II (APM2), a device that monitors very low differential pressure between rooms.

21 Jan 2010

New effort to produce standardized DNA parts for reducing development time of synthetic biology in labs

With seed money from the National Science Foundation (NSF), bioengineers from the University of California, Berkeley, and Stanford University are ramping up efforts to characterize the thousands of control elements critical to the engineering of microbes so that eventually, researchers can mix and match these "DNA parts" in synthetic organisms to produce new drugs, fuels or chemicals.

21 Jan 2010

Researchers explain how HSV dismantles host's defense systems

A viral infection is like an uninvited, tenacious houseguest in the cell, using a range of tricks to prevent its eviction. Researchers at the Salk Institute for Biological Studies have identified one of the key proteins allowing herpes simplex virus (HSV) DNA to fly under the radar of their hosts' involuntary hospitality.

21 Jan 2010

Discovery of new class of compounds may help fight hepatitis C

Stanford University School of Medicine scientists have discovered a novel class of compounds that, in experiments in vitro, inhibit replication of the virus responsible for hepatitis C. If these compounds prove effective in infected humans as well, they may dramatically accelerate efforts to confront this virus’s propensity to rapidly acquire drug resistance, while possibly skirting some of the troubling side effects common among therapies in current use and in late-stage development.

21 Jan 2010

Eating contaminated chicken causes UTI in women

Chicken sold in supermarkets, restaurants and other outlets may place young women at risk of urinary tract infections (UTI), McGill researcher Amee Manges has discovered.

21 Jan 2010

Medizone International files second patent application for AsepticSure

Following the recently announced success achieved during the third round of trials at its research facility at Queen's University (Kingston Ontario, Canada) Medizone International, Inc. announces that a second patent application has been filed which in combination with its previous patent application for AsepticSure™ filed in July of 2009, affords the Company greatly enhanced protection for both the hospital version of AsepticSure™ and the government variant intended for bio-terrorism countermeasures.

21 Jan 2010

Outcomes for STEMI patients improve with early treatment intervention

A recent study found that individuals experiencing chest pain who had electrocardiogram (ECG or EKG) assessments prior to arriving at the hospital experienced a significantly reduced time-to-treatment or door-to-balloon (D2B) time.

21 Jan 2010

Medical student receives 2009 Lucien Rubenstein Award

The American Brain Tumor Association has announced that Alexander Ksendzovsky, a third-year medical student at the Chicago Medical School of Rosalind Franklin University in North Chicago, is the 2009 Lucien Rubenstein Award recipient.

21 Jan 2010

Acyclovir does not reduce risk of HIV transmission for people infected with both HIV and HSV-2

A five-year international multi-center clinical trial has found that acyclovir, a drug widely used as a safe and effective treatment taken twice daily to suppress herpes simplex virus-2 (HSV-2), which is the most common cause of genital herpes, does not reduce the risk of HIV transmission when taken by people infected with both HIV and HSV-2.

21 Jan 2010

Blueberries may help boost memory in older adults

Scientists are reporting the first evidence from human research that blueberries - one of the richest sources of healthful antioxidants and other so-called phytochemicals - improve memory.

21 Jan 2010

Local physicians are currently recruiting PTSD patients for clinical research study

Researchers are currently recruiting patients with civilian post-traumatic stress disorder (PTSD) for a clinical research study called the COPE study. People who are having symptoms after experiencing a traumatic event or who have been diagnosed with PTSD may be eligible to participate in this study of a new investigational drug.

21 Jan 2010

Laboratory News and Research

Study: Warburg effect promotes rapid cell proliferation and tumor growth

USPTO issues new patent for Advaxis' intellectual property portfolio

Findings offer potential significance to the recovery of walking after spinal cord injury

Simple, five minute saliva test to determine baby's risk for more than 100 life-threatening genetic diseases

Rise in US springtime ozone levels could impact compliance with Clean Air Act standards

New study concerning the severity of H1N1 influenza published in CMAJ

Ordinary face masks and hand hygiene can reduce transmission of influenza-like illness

CPRIT awards the first $61M in grants for cancer research

Exalenz Bioscience finalizes production of its BreathID System for detecting H. pylori bacteria

Phoenix Controls announces the introduction of APM2

New effort to produce standardized DNA parts for reducing development time of synthetic biology in labs

Researchers explain how HSV dismantles host's defense systems

Discovery of new class of compounds may help fight hepatitis C

Eating contaminated chicken causes UTI in women

Medizone International files second patent application for AsepticSure

Outcomes for STEMI patients improve with early treatment intervention

Medical student receives 2009 Lucien Rubenstein Award

Acyclovir does not reduce risk of HIV transmission for people infected with both HIV and HSV-2

Blueberries may help boost memory in older adults

Local physicians are currently recruiting PTSD patients for clinical research study

Lab Diagnostics and Automation - Second Edition eBook

Sensing a Healthier Future

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Latest Life Science News